Pink Sheet is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


FDA Says It’s The Law, Denies Petition Requesting GDUFA Fee Payment Changes

This article was originally published in The Pink Sheet Daily

Executive Summary

The agency also says only Congress could enact fee waivers and exemptions, but Square Pharmaceuticals indicates it will join lobbying efforts to create them.


Related Content

Generic User Fee 'Relief' For Small Firms Would Mean Bigger Bills For Large One
Generic User Fees Need Small Business Waiver, Firms Say; Congress May Agree
GDUFA Facility Fees Should Be Waived Until First ANDA Approved, Petition Argues
Generic User Fee Waivers Created In Draft House Bill, Breaking FDA-Industry Agreement





Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts